Biology Reference
In-Depth Information
Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [
3
H]roli-
pram binding activity and their relationship to emetic behavior in the ferret. J Med Chem 39:
120-125
Dyke HJ, Montana JG (2002) Update on the therapeutic potential of PDE4 inhibitors. Expert Opin
Investig Drugs 11:1-13
Ebina M, Takahashi T, Chiba T, Motomiya M (1993) Cellular hypertrophy and hyperplasia of
airway smooth muscles underlying bronchial asthma. A 3D morphometric study. Am Rev
Respir Dis 148:720-726
Eddleston J, Herschbach J, Wagelie-Steffen AL, Christiansen SC, Zuraw BL (2007) The anti-
inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in
epithelial cells. J Allergy Clin Immunol 119:115-122
Edmondson SD, Mastracchio A, He J, Chung CC, Forrest MJ, Hofsess S, MacIntyre E, Metzger J,
O'Connor N, Patel K, Tong X, Tota MR, Van der Ploeg LH, Varnerin JP, Fisher MH,
Wyvratt MJ, Weber AE, Parmee ER (2003) Benzyl vinylogous amide substituted aryldihy-
dropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors.
Bioorg Med Chem Lett 13:3983-3987
Epstein PM, Moraski S Jr, Hachisu R (1987) Identification and characterization of a Ca
2+
-
calmodulin-sensitive cyclic nucleotide phosphodiesterase in a human lymphoblastoid cell
line. Biochem J 243:533-539
Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ (1997) A comparison of
low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate
asthma. N Engl J Med 337:1412-1418
Ezeamuzie CI (2001) Requirement of additional adenylate cyclase activation for the inhibition of
human eosinophil degranulation by phosphodiesterase IV inhibitors. Eur J Pharmacol 417:
11-18
Farrow SN (2008) Nuclear receptors: doubling up in the lung. Curr Opin Pharmacol 8:275-279
Fischer TA, Palmetshofer A, Gambaryan S, Butt E, Jassoy C, Walter U, Sopper S, Lohmann SM
(2001) Activation of cGMP-dependent protein kinase I
b
inhibits interleukin 2 release
and proliferation of T cell receptor-stimulated human peripheral T cells. J Biol Chem 276:
5967-5974
Fujimura M, Kamio Y, Saito M, Hashimoto T, Matsuda T (1995) Bronchodilator and
bronchoprotective effects of cilostazol in humans in vivo. Am J Respir Crit Care Med 151:
222-225
Gaillard E, Bruck N, Brelivet Y, Bour G, Lalevee S, Bauer A, Poch O, Moras D, Rochette-Egly C
(2006) Phosphorylation by PKA potentiates retinoic acid receptor
a
activity by means of
increasing interaction with and phosphorylation by cyclin H/cdk7. Proc Natl Acad Sci USA
103:9548-9553
Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess
G, Branzi A, Grimminger F, Kurzyna M, Simonneau G (2005) Sildenafil citrate therapy for
pulmonary arterial hypertension. N Engl J Med 353:2148-2157
Gamble E, Grootendorst DC, Brightling CE, Troy S, Qiu Y, Zhu J, Parker D, Matin D,
Majumdar S, Vignola AM, Kroegel C, Morell F, Hansel TT, Rennard SI, Compton C,
Amit O, Tat T, Edelson J, Pavord ID, Rabe KF, Barnes NC, Jeffery PK (2003) Anti-inflammatory
effects of
the phosphodiesterase-4 inhibitor cilomilast
(
Ariflo
)
in chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 168:976-982
Gantner F, Gotz C, Gekeler V, Schudt C, Wendel A, Hatzelmann A (1998) Phosphodiesterase
profile of human B lymphocytes from normal and atopic donors and the effects of PDE
inhibition on B cell proliferation. Br J Pharmacol 123:1031-1038
Gantner F, Schudt C, Wendel A, Hatzelmann A (1999) Characterization of the phosphodiesterase
(PDE) pattern of in vitro - generated human dendritic cells (DC) and the influence of PDE
inhibitors on DC function. Pulm Pharmacol Ther 12:377-386
Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadas B,
Schermuly RT, Weissmann N, Seeger W, Grimminger F (2004) Differences in hemodynamic
